Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Selective class IIa HDAC inhibitors: myth or reality
Eros Di Giorgio, Enrico Gagliostro, Claudio Brancolini
Cellular and Molecular Life Sciences (2014) Vol. 72, Iss. 1, pp. 73-86
Closed Access | Times Cited: 52

Showing 26-50 of 52 citing articles:

MC1568 Enhances Histone Acetylation During Oocyte Meiosis and Improves Development of Somatic Cell Nuclear Transfer Embryos in Pig
Huili Wang, Wei Cui, Chunhua Meng, et al.
Cellular Reprogramming (2018) Vol. 20, Iss. 1, pp. 55-65
Closed Access | Times Cited: 29
The MEF2–HDAC axis controls proliferation of mammary epithelial cells and acini formation in vitro
Andrea Clocchiatti, Eros Di Giorgio, Giulia Viviani, et al.
Journal of Cell Science (2015) Vol. 128, Iss. 21, pp. 3961-3976
Open Access | Times Cited: 28
Fragment based G-QSAR and molecular dynamics based mechanistic simulations into hydroxamic-based HDAC inhibitors against spinocerebellar ataxia
Siddharth Sinha, Chetna Tyagi, Sukriti Goyal, et al.
Journal of Biomolecular Structure and Dynamics (2015) Vol. 34, Iss. 10, pp. 2281-2295
Open Access | Times Cited: 28
A Fluorescence‐Lifetime‐Based Binding Assay for Class IIa Histone Deacetylases
Christian Meyners, Monique Mertens, Pablo Wessig, et al.
Chemistry - A European Journal (2016) Vol. 23, Iss. 13, pp. 3107-3116
Closed Access | Times Cited: 25
Statins and Histone Deacetylase Inhibitors Affect Lamin A/C – Histone Deacetylase 2 Interaction in Human Cells
Elisabetta Mattioli, Davide Andrenacci, Antonello Mai, et al.
Frontiers in Cell and Developmental Biology (2019) Vol. 7
Open Access | Times Cited: 23
Quis Custodiet Ipsos Custodes (Who Controls the Controllers)? Two Decades of Studies on HDAC9
Claudio Brancolini, Eros Di Giorgio, Luigi Formisano, et al.
Life (2021) Vol. 11, Iss. 2, pp. 90-90
Open Access | Times Cited: 18
The Novel Class IIa Selective Histone Deacetylase Inhibitor YAK540 Is Synergistic with Bortezomib in Leukemia Cell Lines
Lukas M. Bollmann, Alexander Jan Skerhut, Yodita Asfaha, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 13398-13398
Open Access | Times Cited: 13
Epi-drugs as triple-negative breast cancer treatment
Mouhamed Idrissou, Anna Sánchez, Frédérique Penault‐Llorca, et al.
Epigenomics (2020) Vol. 12, Iss. 8, pp. 725-742
Closed Access | Times Cited: 17
The histone deacetylase Hdac7 supports LPS-inducible glycolysis and Il-1β production in murine macrophages via distinct mechanisms
Divya Ramnath, Kaustav Das Gupta, Yizhuo Wang, et al.
Journal of Leukocyte Biology (2021) Vol. 111, Iss. 2, pp. 327-336
Closed Access | Times Cited: 15
Histone Deacetylase Inhibitors as Cognitive Enhancers and Modifiers of Mood and Behavior
Dilipkumar Pal, Pooja Sahu, Abhishek Kumar Mishra, et al.
Current Drug Targets (2022) Vol. 24, Iss. 9, pp. 728-750
Closed Access | Times Cited: 11
The Class IIA Histone Deacetylase (HDAC) Inhibitor TMP269 Downregulates Ribosomal Proteins and Has Anti-Proliferative and Pro-Apoptotic Effects on AML Cells
Laura Urwanisch, Michael S. Unger, Helene Sieberer, et al.
Cancers (2023) Vol. 15, Iss. 4, pp. 1039-1039
Open Access | Times Cited: 6
5-(Trifluoromethyl)-1,2,4-oxadiazole (TFMO)-based highly selective class IIa HDAC inhibitors exhibit synergistic anticancer activity in combination with bortezomib
Yodita Asfaha, Lukas M. Bollmann, Alexander Jan Skerhut, et al.
European Journal of Medicinal Chemistry (2023) Vol. 263, pp. 115907-115907
Closed Access | Times Cited: 6
Class II histone deacetylases require P/Q-type Ca2+ channels and CaMKII to maintain gamma oscillations in the pedunculopontine nucleus
Francisco J. Urbano, Verónica Bisagno, Susan Mahaffey, et al.
Scientific Reports (2018) Vol. 8, Iss. 1
Open Access | Times Cited: 17
MEF-2 isoforms' (A-D) roles in development and tumorigenesis
Kiran Madugula, Ria Mulherkar, Zafar K. Khan, et al.
Oncotarget (2019) Vol. 10, Iss. 28, pp. 2755-2787
Open Access | Times Cited: 17
Mechanistic Insights into the Binding of Class IIa HDAC Inhibitors toward Spinocerebellar Ataxia Type-2: A 3D-QSAR and Pharmacophore Modeling Approach
Siddharth Sinha, Sukriti Goyal, Pallavi Somvanshi, et al.
Frontiers in Neuroscience (2017) Vol. 10
Open Access | Times Cited: 15
Design and synthesis of peptides as stabilizers of histone deacetylase 4
Annika Lill, Markus Schweipert, Thomas Nehls, et al.
Journal of Peptide Science (2024) Vol. 30, Iss. 9
Open Access | Times Cited: 1
Dissecting transposable elements and endogenous retroviruses upregulation by HDAC inhibitors in leiomyosarcoma cells: Implications for the interferon response
Nicolò Gualandi, Martina Minisini, Alessio Bertozzo, et al.
Genomics (2024) Vol. 116, Iss. 5, pp. 110909-110909
Open Access | Times Cited: 1
Promiscuous actions of small molecule inhibitors of the protein kinase D‐class IIa HDAC axis in striated muscle
Douglas D. Lemon, Brooke C. Harrison, Todd R. Horn, et al.
FEBS Letters (2015) Vol. 589, Iss. 10, pp. 1080-1088
Open Access | Times Cited: 10
Diarylcyclopropane hydroxamic acid inhibitors of histone deacetylase 4 designed by combinatorial approach and QM/MM calculations
Jakub Kollár, Vladimı́r Frecer
Journal of Molecular Graphics and Modelling (2018) Vol. 85, pp. 97-110
Closed Access | Times Cited: 4
Structure-based identification of novel histone deacetylase 4 (HDAC4) inhibitors
Rupesh Agarwal, Pawat Pattarawat, Michael R. Duff, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 3
Structure-Based Identification of Novel Histone Deacetylase 4 (HDAC4) Inhibitors
Rupesh Agarwal, Pawat Pattarawat, Michael R. Duff, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 7, pp. 867-867
Open Access
Super-enhancers reorganization controls re-sensitization of oxaliplatin-resistant FBXW7-mutated colorectal cancer
Eros Di Giorgio, Vanessa Tolotto, Nicolò Gualandi, et al.
Research Square (Research Square) (2024)
Open Access
Synthesis and Characterization of Reversible Covalent HDAC4 Inhibitors
Anton Frühauf, Benjamin Wolff, Markus Schweipert, et al.
Methods in molecular biology (2022), pp. 207-221
Closed Access | Times Cited: 1
An investigation into Mef2-interacting proteins during embryonic muscle development of Drosophila
Alina Cepraga
(2020)
Closed Access
Synthesis of novel pyridazino[1,6-a]indole-2,4(1H,3H)-dione and pyridazino[1,6-a]indol-2(1H)-one via intramolecular electrophilic aromatic substitution
Katarzyna Ozdarska, Maud Petremant, Kai‐Chen Wu, et al.
Results in Chemistry (2022) Vol. 4, pp. 100612-100612
Open Access

Scroll to top